Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial

BMC cancer

Volumn 13, Issue , 2013, Pages 299-

  Solomón, Maria T eresa ^a   Selva, Julio C ésar ^a   Figueredo, Javier ^a   Vaquer, José ^a   Toledo, Carolina ^a   Quintanal, Nelson ^a   Salva, Silvia ^a   Domíngez, Rafael ^a   Alert, José ^a   Marinello, Jorge J uan ^a   Catalá, Mauricio ^a   Griego, Martha G onzález ^a   Martell, Juan A ntonio ^a   Luaces, Patricia L orenzo ^a   Ballesteros, Javier ^a   de Castro, Niurys ^a   Bach, Ferdinand ^a   Crombet, Tania ^a  

^a HOSPITAL UNIVERSITARIO GENERAL CALIXTO GARCÍA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; NIMOTUZUMAB;

ADULT; BRAIN NEOPLASMS; CANCER GRADING; CHEMORADIOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLIOMA; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; DOUBLE-BLIND METHOD; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING;

EID: 84879042760     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-299     Document Type: Article

References (0)